Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101 Meeting Abstract
| Authors: | Shulman, L. N.; Berry, D. A.; Cirrincione, C. T.; Becker, H.; Perez, E. A.; O'Regan, R.; Martino, S.; Shapiro, C. L.; Atkins, J.; Schneider, C.; Kimmick, G. G.; Burstein, H. J.; Norton, L.; Musa, H. B.; Hudis, C.; Winer, E. P. |
| Abstract Title: | Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101 |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-13 |
| Language: | English |
| ACCESSION: | WOS:000335419600229 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.1007 |
| Notes: | Meeting Abstract: 1007 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
